S49.139S Salter-Harris Type III physeal fracture of lower end of humerus, unspecified arm, sequela

Name of the Condition

• Salter-Harris Type III physeal fracture of lower end of humerus, unspecified arm, sequela (ICD-10 Code: S49.139S)

Summary

This code describes a Salter-Harris Type III fracture involving the growth plate (physeal) at the lower end of the humerus, with the "sequela" modifier indicating residual effects following the acute injury phase. The fracture extends through the growth plate and into the adjacent epiphysis (the end of the bone). It is most common in children and adolescents due to the relative weakness of the growth plate during development. The injury affects the distal humeral physis, where the upper arm bone meets the elbow joint, and the unspecified arm designation indicates the side is not documented. The sequela modifier applies when the condition is a late effect of the fracture, such as chronic pain, deformity, or functional impairment.

Causes

Trauma is the primary cause, often resulting from a fall onto an outstretched hand or a direct blow to the elbow. Sports-related injuries, such as those from contact sports or activities involving forceful arm movement, are frequent mechanisms. The force applied to the elbow can disrupt the growth plate and extend into the epiphysis, potentially affecting joint alignment. The sequela phase occurs after the acute injury has healed, with residual effects persisting due to incomplete recovery or complications.

Risk Factors

• Age (most common in children and adolescents with open growth plates)
• Participation in high-impact or contact sports
• Prior growth plate injuries or developmental abnormalities
• Activities involving repetitive stress on the elbow

Symptoms

• Chronic pain or discomfort in the elbow or lower arm
• Reduced range of motion or stiffness
• Visible deformity or malalignment of the arm
• Functional limitations, such as difficulty with daily activities or sports
• Possible nerve or vascular impairment in severe cases

Diagnosis

Diagnosis involves a thorough clinical evaluation, including a review of the patient’s medical history and mechanism of injury. Physical examination assesses for deformity, swelling, or tenderness. Imaging studies, such as X-rays or MRI, may be used to evaluate the residual effects of the fracture, including joint alignment, bone healing, or associated complications. The sequela modifier is applied when the condition is a late effect of the original fracture, confirmed by clinical findings and imaging.

Treatment Options

Treatment focuses on managing residual symptoms and improving function. Conservative measures may include physical therapy to restore range of motion and strength, pain management, and activity modification. Surgical intervention may be considered for severe deformity or functional impairment, such as osteotomy or joint reconstruction. The approach depends on the extent of residual effects and the patient’s functional goals.

Prognosis and Follow-Up

Prognosis varies based on the severity of the residual effects and the success of treatment. Most patients experience improvement with appropriate management, though some may have long-term limitations. Regular follow-up is recommended to monitor for complications, such as arthritis or growth disturbances, and to adjust treatment as needed. Long-term outcomes depend on the initial injury severity and adherence to rehabilitation.

Complications

• Chronic pain or stiffness
• Joint deformity or malalignment
• Early-onset arthritis due to altered joint mechanics
• Growth disturbances, particularly if the growth plate was affected
• Nerve or vascular damage, though rare in the sequela phase

Lifestyle & Prevention

• Avoid high-impact activities that stress the elbow joint
• Use protective equipment during sports or recreational activities
• Engage in regular, low-impact exercise to maintain joint mobility and strength
• Follow rehabilitation protocols to optimize recovery and minimize residual effects

When to Seek Professional Help

Seek medical attention if residual symptoms worsen, new pain or deformity develops, or functional limitations interfere with daily activities. Prompt evaluation is important to address complications or adjust treatment plans.

Tips for Medical Coders

This code is used for the sequela of a Salter-Harris Type III physeal fracture of the lower humerus. Document the residual effects, such as chronic pain, deformity, or functional impairment, to support the sequela modifier. Ensure the fracture type, location, and arm specification are clearly documented. The sequela phase applies when the condition is a late effect of the original injury, distinct from acute or healing phases.